Piper Jaffray Expands Biotechnology Research Platform with Addition of Josh Schimmer, MD
November 07 2013 - 8:53AM
Business Wire
Piper Jaffray (NYSE: PJC) is pleased to announce the hiring of
Josh Schimmer, MD as a managing director and senior research
analyst based in the firm’s New York office. Schimmer will be
focused on small- and mid-cap biotechnology companies with specific
emphasis in core therapeutic areas, commercialization and strategic
partnerships.
Schimmer brings more than 10 years of experience to Piper
Jaffray. He joined the firm from Lazard Capital Markets, and was
previously at Cowen & Co., Leerink Swann, Deutsche Banc and
Davidson Kempner. Schimmer holds a doctorate of medicine from the
University of Toronto and a Master of Business Administration
degree from Harvard Business School.
"Piper Jaffray has a strong team of healthcare professionals and
we are excited to be adding another research specialist in
biotechnology with Josh's hire," commented Steph Wissink,
co-director of equity research for Piper Jaffray. "With increased
emphasis on core growth areas of biotech, we see opportunities to
serve the needs of our clients and build upon our market-leading
healthcare platform."
Piper Jaffray has a total of 30 senior research analysts
located in Minneapolis, New York, San Francisco
and Chicago. The firm provides coverage on approximately 575
companies in the following key sectors: business & financial
services; clean technology & industrial growth; consumer;
healthcare; and technology, media & telecommunications.
About Piper JaffrayPiper Jaffray is a leading investment
bank and asset management firm serving clients in the U.S. and
internationally. Proven advisory teams combine deep industry,
product and sector expertise with ready access to capital. Founded
in 1895, the firm is headquartered in Minneapolis and has offices
across the United States and in London and Zurich.
www.piperjaffray.com
Since 1895. Member NYSE and SIPC.© 2013 Piper Jaffray &
Co.
Piper Jaffray CompaniesPamela Steensland, +1 612-303-8184
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Piper Jaffray Companies (New York Stock Exchange): 0 recent articles
More Piper Jaffray Companies News Articles